Cryptic insertion (15;17) in a case of acute promyelocytic leukemia detected by fluorescence in situ hybridization

Haematologica. 1999 Jan;84(1):88-90.
No abstract available

Publication types

  • Case Reports
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Antineoplastic Agents / therapeutic use
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Biomarkers, Tumor / genetics*
  • Chromosomes, Human, Pair 15 / genetics*
  • Chromosomes, Human, Pair 17 / genetics*
  • Cytarabine / administration & dosage
  • Etoposide / administration & dosage
  • Fatal Outcome
  • Hematopoietic Stem Cell Transplantation
  • Humans
  • In Situ Hybridization, Fluorescence*
  • Leukemia, Promyelocytic, Acute / drug therapy
  • Leukemia, Promyelocytic, Acute / genetics*
  • Leukemia, Promyelocytic, Acute / therapy
  • Male
  • Mitoxantrone / administration & dosage
  • Neoplasm Proteins / genetics*
  • Oncogene Proteins, Fusion / genetics*
  • Reverse Transcriptase Polymerase Chain Reaction
  • Translocation, Genetic*
  • Tretinoin / administration & dosage
  • Tretinoin / therapeutic use

Substances

  • Antineoplastic Agents
  • Biomarkers, Tumor
  • Neoplasm Proteins
  • Oncogene Proteins, Fusion
  • promyelocytic leukemia-retinoic acid receptor alpha fusion oncoprotein
  • Cytarabine
  • Tretinoin
  • Etoposide
  • Mitoxantrone